Additionally, since the expression of both genes is significantly up-regulated after a singlehigh dose of γ-radiation, but remained unchanged in treated thymic-lymphoma-free-mice, epigenetic down-regulation of E-and N-cadherin appears to occur concomitantly with the progression towards the most advanced stages of γ-radiation-induced thymic lymphomas.
Introduction
Gamma-radiation-induced thymic lymphomas consist of a heterogeneous group of T-cell lymphoblastic lymphomas characterized by an uncontrolled expansion of immature T-cell precursors that fail to complete differentiation. A number of papers have shown that alterations of several oncogenes and tumour suppressor genes expressed by thymocytes help explain the development of this kind of lymphomas (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) . Still the thymus is a heterogeneous lobed organ having also stromal cells that provide a variety of microenvironments where thymocytes proliferate and mature (13) . As of this writing there are no reports recording genetic alterations of critical genes expressed by stromal cells during the origin and/or progression of thymic lymphomas.
In order to characterize the pattern of expression of some of these genes, our research focused on E-and N-cadherin that are respectively expressed by stromal epithelial and mesenchymal cells. Classical cadherins encode for a group of membrane receptors that mediate calciumdependent homotypic (and sometimes heterotypic) cell-to-cell adhesion. These proteins might be involved in the maintenance of haematopoietic stem cells, acting as a negative regulator of WNT-pathway signalling by binding thereby and sequestering β-catenin from the nucleus.
Alternatively, the accumulation of β-catenin in the cytoplasm may facilitate its displacement to the nucleus, where it would bind to the transcriptional factor Tcf thereby stimulating transcription of target genes involved in cell proliferation and differentiation (13, 14, 15) .
In mice both stromal epithelial cells as well as fetal thymocytes and a fraction of the neonatal and adult T-cells clearly express E-cadherin (16, 17) . Interestingly, the progression of doublenegative (CD4-CD8-) to double-positive (CD4+CD8+) thymocytes may be disturbed after at Pennsylvania State University on February 23, 2013 http://carcin.oxfordjournals.org/ Downloaded from 4 inhibition of the homotypic E-cadherin interactions (18) . Furthermore, interactions of thymic epithelial cells (expressing E-cadherin) with CD103+ thymocytes (expressing α E (CD103)β 7 integrin) can lead to enhanced thymocyte proliferation in human (19) . Several other classical cadherins (Cadherin-6, 8 and 11) have been also found by RT-PCR on murine thymocytes, though these studies have not been confirmed on immunological ground (17) . In human bone marrow N-cadherin is expressed by early haematopoietic progenitor cells (CD34+CD19+) but is down-regulated by more mature progenitor cells (20) .
In oncogenesis, both a loss of the epithelial E-cadherin (Cdh1) and a gain of the mesenchymal cadherins such as N-cadherin (Cdh2) have been reported during the progression of many solid tumours (14) . Still, the role of cadherins in primary haematological malignancies is only starting to be recognized (21) (22) (23) (24) . For this reason, it is reasonable to think that the study of these members of the cadherin family in the thymus may help us reach a more precise knowledge of the molecular alterations underlying the progression of thymic lymphomas.
In this study we report that in the thymus of mice E-cadherin is essentially expressed by stromal cells and to a lesser extent by thymocytes, whereas N-cadherin is only expressed by stromal cells. In addition, the analysis of a sample series of γ-radiation induced murinethymic-lymphomas, revealed significant reductions of both E-cadherin and N-cadherin in all tumours examined suggesting the existence of epigenetic control events. For such reasons we propose that the down-regulation of stromal E-and N-cadherin in these cells may be contributing to the development of primary thymic lymphomas. 
Material and Methods

Mice and tumour induction
Reciprocal inter-strain crosses, involving males and females from the BALB/cJ and C57BL/6J strains were carried out in order to generate F1 hybrid mice. Five adult mice were treated with a single-high dose of γ-radiation (10 Gy) and sacrificed 24 hours later. A series of 14 thymic lymphomas were obtained by whole body γ-radiation of 17 adult mice split into four weekly doses of 1.75 Gy as described in a previous work (25) . Five additional thymic lymphomas were induced in C57BL/6J mice. All of the tumour samples were frank T-cell lymphomas in their most advanced stage of development.
Sample cell fractionation
Samples from three thymic lymphomas, two thymuses of mice treated with a single-high dose, and three control-healthy thymuses from C57BL/6J mice were washed and strained through a nylon mesh (BD Falcon Cell Strainer, BD Biosciences, Belgium). Stroma-enriched cell fractions were obtained by collagenase digestion according to a previously described method (26) . This procedure allows for the discrimination of a significant amount of stromal cells (including epithelium, endothelium, reticular fibroblasts, macrophages, dendritic cells and neuroendocrine cells) from other cells (CD45 -) derived from the haematopoietic stem cells. Thymocyte isolation was carried out by centrifugation on Ficoll-Hypaque (Pharmacia Biotech, Upsala, Sweden) as previously described (27) . Thymocytes were afterwards positively selected by magnetic sorting using the Pan T cell Isolation kit (Miltenyi Biotec Gmbh, BG, Germany). The purity of the isolated thymocytes was confirmed through flow cytometry (Cytomics FC 500 Series Flow Cytometry Systems, Beckman Coulter, Fullerton, CA) using fluorescein isothiocyanate (FITC)-conjugated anti-CD3 (Becton Dickinson, 
Histopathology and immunofluorescence staining
For histopathology two control thymuses from C57BL/6J and two γ-radiation-induced thymic lymphomas were fixed with 4% formaldehyde in phosphate buffered saline (PBS) overnight at 4ºC, and embedded in paraffin. Tissue sections were prepared, stained with hematoxylin and eosin and examined under the microscope. Immunofluorescence staining was also performed on fine tissue sections (2 µm) of control thymuses and thymic lymphomas using Subsequently, the membrane was washed and incubated in Lumi-Light PLUS Western Blotting Substrate (Roche) and exposed to X-ray film. Positive control for E-and N-cadherin was obtained from HaCaT cells and brain samples, respectively. In addition, anti-β-actin antibody (Sigma, St. Louis, MO) was used as a loading control. (methylated) and negative (non-methylated) controls, respectively. The PCR products were loaded on a 2% agarose gel and visualized with ethidium bromide. All of the assays were repeated three times, and methylated CpG sites were confirmed by DNA sequencing using the following primers: Cdh1 bisulfite sequencing primers, 5´-
Results
Histopathological analysis
As reported by other studies, control thymuses from C57BL/6J mice exhibit a clear distinction between the cortex and the medulla (Figure 1a Figure 3b ). The expression of E-cadherin was also studied using protein samples from stromal cells and isolated thymocytes. Consistent with the transcriptional data, the amount of protein detected in stromal cells of three of the tumours was found to lie between those observed in whole control thymuses and those of thymic lymphomas (data not shown). Previous works have demonstrated that E-cadherin is frequently silenced by promoter hypermethylation in many other cancer types (29) . For such reasons we were interested in determining whether or not the down-regulation of E-and N-cadherin could be attributed to epigenetic mechanisms. To this end, MSP/sequentiation analyses were conducted on genomic DNA from these tumours in order to screen for aberrant methylation at their promoter regions.
Hypermethylation in tumour samples
The methylation status of the Cdh1 promoter was determined by evaluating the methylation density of 27 CpG sites spanning the -223 and +157 bp region of the Cdh1 sequence ( Figure   4 , and Table I ). Cdh1 promoter hypermethylation on this critical region was recorded in 4 out of 14 (i.e., 28.57%) of the analyzed tumours ( Figure 4a ). DNA sequencing of bisulphitetreated DNA using external primers allowed us to further corroborate these results ( Figure   4b ). Although Cdh1 promoter hypermethylation was always associated with a clear reduction in the levels of gene expression (Table 1) , it did not reach statistical significance (Student-t test p>0,01), suggesting the existence of additional mechanisms for Cdh1 inactivation in these tumours.
N-cadherin promoter hypermethylation was detected in 12 out of 14 (i.e., 85.71%) of the analyzed tumours (Figure 5a ; Table I ). As in the previous case, a sequencing analysis using external primers corroborated these results, with nineteen methylated CpG dinucleotides around the transcription start site (Figure 5b ). All of the 12 methylated tumours exhibited reduced levels of mRNA transcription while one of the two un-methylated tumours expressed detectable levels of expression (in fact, similar to or even higher than those of the control samples) (Table I) . Interestingly, we found a significant decrease in the level of expression of this gene between methylated and unmethylated tumors (Student-t test, p<0,05).
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In order to determine whether the observed methylation changes are the consequence of tumorigenesis or just radiation/aged, we analysed the methylation status of Cdh1 and Cdh2 in tumor-free mice after aging or radiation treatments (single high doses and four lower doses).
Interestingly we have not detected significant changes in the status of promoter methylation in any case with respect to the control samples (data not shown).
Transcriptional expression of Snai1.
As 10 out of the 14 thymic lymphomas exhibited reduced mRNA E-cadherin expression but did not display promoter hypermethylation, we finally tested whether these tumours exhibited an increased expression of Snai1, a gene capable of inhibiting E-cadherin (39) . Interestingly, three of these tumours showed an over-expression of Snai1 (Table I) (22) . In humans, N-cadherin has also been detected in T-cell leukaemia and lymphoma cells but not on normal leukocytes (23, 24) . To this day, however, no one has reported anything on the role played by these cadherins in primary thymic lymphomas.
Using immunofluorescence and quantitative fluorescence-real-time RT-PCR experimental approaches we confirmed that stromal cells of control thymuses express significant amounts of E-cadherin mRNA, and demonstrated for the first time that the stromal cells likewise express N-cadherin mRNA even though at more reduced levels. Isolated thymocytes also expressed small amounts of E-cadherin mRNA yet failing to produce detectable levels of mRNA from the N-cadherin gene.
As expected, the analysis on a sample series of advanced murine thymic lymphomas induced by γ-rays evidenced a significant reduction of both the E and N-cadherin expression in almost all of the tumours, suggesting that inhibition of both genes may be critical in the progression towards the most advanced stages of lymphomagenesis. These hypotheses might be supported by the fact that in thymuses from treated-lymphoma-free mice the levels of E-cadherin did not differ significantly when compared to those detected in control non-treated thymuses.
However, it should be stressed that thymuses from mice exposed to single-high doses of radiation and sacrificed 24 hours later experienced a considerable over-expression of both genes. This early response to radiation could be indicating that, contrary to the situation recorded in the most advances stages, high levels of E-and N-cadherin may be favouring the initial stages of tumorigenesis. This is probably accomplished by enhancing thymocyte cell proliferation through adhesive interactions between thymic epithelial cells and thymocytes mediated by the E-cadherin-CD103 integrin-ligand-pair (19) .
With regard to thymic lymphomas down-regulation of both genes appears to occur concomitantly with the progression towards the most advances stages of lymphomagenesis. In Although there is precedent for this (43) , to the best of our knowledge this has been not reported in lymphomas. We propose that an early over-expression of both E-and N-cadherin in response to single-high doses of radiation may be favouring the initial stages of limphomagenesis probably by enhancing thymocyte proliferation. However, the histopathological disorganization that occurs in the structure of the frank lymphomas in the most advanced stages of tumorigenesis could, at least in part, be attributed to the epigenetic down-regulation of both E-and N-cadherin. In this regard, we have recently demonstrated that new drugs with DNA demethylating activity, such as zebularine, are able to restore Ecadherin expression and at the same time are effective against the development of the described mouse T-lymphomas (44) . at Pennsylvania State University on February 23, 2013 
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